Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Consolidated Net Profit

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹364 Cr₹260 Cr₹300 Cr₹164 Cr₹64 Cr

What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?

The latest Consolidated Net Profit ratio of NEULAND LABORATORIES is ₹364 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹364 Cr
Mar2025₹260 Cr
Mar2024₹300 Cr
Mar2023₹164 Cr
Mar2022₹64 Cr

How is Consolidated Net Profit of NEULAND LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹364 Cr
39.94
Mar2025 ₹260 Cr
-13.32
Mar2024 ₹300 Cr
83.51
Mar2023 ₹164 Cr
156.21
Mar2022 ₹64 Cr -

Compare Consolidated Net Profit of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹24,284.5 Cr -6.1% -17.1% 18% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -0.2% -4.9% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,904.0 Cr 1.3% -2.3% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹172,213.0 Cr -1.5% -5.8% 29.3% Stock Analytics
CIPLA ₹106,138.0 Cr 0.1% -4.2% -14.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,304.0 Cr 1.9% 5.7% 0.4% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-6.1%

-17.1%

18%

SENSEX

0.9%

-0.8%

-10.5%


You may also like the below Video Courses